Overview of Systemic Therapies in Penile Cancer - 24/06/24
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
Résumé |
Penile cancer (PC), although rare, poses significant challenges in both diagnosis and treatment. Penile squamous cell carcinoma (PSCC) represents the most common histologic subtype of PC, accounting for approximately 95% of cases. With limited therapeutic options available, systemic therapies have emerged as critical components in the management of advanced PSCC. Recent developments in clinical research have revealed the effectiveness of new therapeutic strategies. By elucidating the mechanism of action and clinical evidence supporting these treatments, we strive to offer insights into optimizing treatment strategies and enhancing the quality of care for patients affected by this complex disease.
Le texte complet de cet article est disponible en PDF.Keywords : Penile cancer, Systemic therapy, Chemotherapy, Targeted, ADC, HPV
Plan
Vol 51 - N° 3
P. 347-354 - août 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?